Intrinsic Edge Capital Management LLC Dexcom Inc Transaction History

Intrinsic Edge Capital Management LLC

$782 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $1.82 Million - $2.32 Million	-16,506 Reduced 40.16%	24,591 $2.79 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $4.69 Million - $5.76 Million	41,097 New	41,097 $5.7 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $2.58 Million - $4.14 Million	30,000 Added 97.23%	60,854 $5.68 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $7.09 Million - $8.38 Million	-68,167 Reduced 68.84%	30,854 $3.58 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $1.63 Million - $2.36 Million	-19,219 Reduced 16.25%	99,021 $11.2 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $4.58 Million - $5.65 Million	60,000 Added 103.02%	118,240 $9.52 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $2.97 Million - $5.8 Million	43,680 Added 300.0%	58,240 $4.34 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $225,324 - $282,492	-1,735 Reduced 10.65%	14,560 $7.82 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $1.88 Million - $2.52 Million	-17,590 Reduced 51.91%	16,295 $8.91 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $1.51 Million - $2.01 Million	18,607 Added 121.79%	33,885 $14.5 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $2.12 Million - $2.62 Million	-25,046 Reduced 62.11%	15,278 $5.49 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $1.79 Million - $2.39 Million	22,885 Added 131.23%	40,324 $14.9 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $735,809 - $870,166	7,704 Added 79.14%	17,439 $7.19 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $1.21 Million - $2.03 Million	-19,260 Reduced 66.43%	9,735 $3.95 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1.39 Million - $2.19 Million	28,995 New	28,995 $7.81 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.

Account